by Madaline Spencer | Apr 21, 2025
Michael Weiss, MD, Department of Neurology, University of Washington Medical Center, discusses results from the RAISE clinical trial testing the safety and efficacy of zilucoplan in patients with myasthenia gravis (MG). MG is a chronic autoimmune...
by Madaline Spencer | Apr 18, 2025
Richard Lafayette, MD, Professor of Medicine, Nephrology and Director of the Glomerular Disease Center at Stanford University Medical Center, discusses the recent approval of Vanrafia (atrasentan) for patients with IgA nephropathy (IgAN). IgAN is a rare...
by Madaline Spencer | Apr 17, 2025
A recent study published in The Journal of Clinical Endocrinology & Metabolism analyzed the use of digital voice analysis as a biomarker of acromegaly. Acromegaly is an endocrine disorder resulting from the overproduction of growth hormone in the pituitary gland....
by Madaline Spencer | Apr 16, 2025
Carla Nester, MD, Professor of Pediatrics-Nephrology at the University of Iowa, discusses the recent U.S. Food and Drug Administration (FDA) approval of iptacopan as the first and only treatment of adults with C3 glomerulopathy (C3G). C3G is a rare...
by Madaline Spencer | Apr 15, 2025
A recent study published in the American Journal of Ophthalmology observed clinical outcomes in patients with peripheral ulcerative keratitis (PUK). Peripheral Ulcerative Keratitis PUK is an inflammatory disease characterized by peripheral corneal thinning. It...
